Browsing Tag
uTRACE
2 posts
Curasight enters clinic with uTREAT for glioblastoma, advancing dual radiopharma strategy
Curasight starts first-in-human trial of uTREAT in glioblastoma, launching its therapeutic radiopharmaceutical program. Read the full strategic analysis.
EMA clears Curasight’s uTREAT trial—will targeted radiopharma redefine brain cancer therapy?
Curasight wins EMA approval for its first uTREAT clinical trial in glioblastoma. Find out how its theranostic strategy could change brain cancer treatment.